StonvexLoading…
StonvexStonvexStonvexCore line items from NRDS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $222.20M | $836.60M | $611.20M | $396.10M |
Operating Income | $27.20M | $65.20M | $45.80M | $11.40M |
Net Income | $20.40M | $48.70M | $34.70M | $8.20M |
EPS (Diluted) | $0.29 | $0.64 | $0.45 | $0.11 |
Total Assets | $432.00M | $461.10M | $492.80M | $476.00M |
Total Liabilities | $95.80M | $86.60M | $90.40M | $86.00M |
Cash & Equivalents | $56.30M | $98.30M | $120.60M | $105.30M |
Free Cash Flow OCF − CapEx | $35.30M | $130.30M | $91.70M | $43.30M |
Shares Outstanding | 65.79M | 71.29M | 74.73M | 75.22M |